Each client is unique. 
So is the team needed to carry out their project

Scientist looking through a microscope
top_bars_icon

Thanks to our extensive network and versatility, we provide the best experts in every field, both in human or veterinary medicine. We also welcome surgeons and experts provided by sponsors to assist with the projects.

Our approach involves an ad hoc team, a tailored model and solid results. We are open and flexible because we value the uniqueness of each case and we thrive on accessible innovation.

Ready to achieve your project goals

Such an extensive network of experts in different therapeutic areas offers multiple advantages. Amongst them:

icon Widen our expertise areas
icon Extend our capabilities
icon Reduce risks
icon Ensure data relevance
icon Accelerate timings
icon Leverage experience portfolio

The role of experts in our work process

Our network of experts and collaborating partners, with their expertise, complements and enriches the work of our team to achieve our sponsors' objectives in the most efficient way possible. Including both the protocol preparation and the study execution.

After defining the protocol to follow and gathering the necessary authorizations to carry out a specific project, we enter the phase of inclusion and execution of the study.

  • 01
    Protocol & Authorization
    Animal Welfare Body & Ethical Comitte
  • 02
    Inclusion + Study execution

    Surgeon and other experts

    Histopathology, Bioanalysis, Specific test or imaging

  • 03
    Final report
    Delegated phase final reports

Meet our collaborators

We increasingly have more specialized professionals when assembling the ad hoc teams that carry out each project we develop. These are the professionals and partners we have collaborated with so far:

01 / Experts in human and veterinary medicine

Please specify the types of professionals or therapeutic areas that interest you:

Fuco Novoa

Fuco Novoa

Clinical veterinarian (MD) Expert in Endoscopy

Dr Santiago Candela Canto, PhD

Dr Santiago Candela Canto, PhD

Degree in Medicine and Surgery and Doctor cum laude from the University of Barcelona

Dr Josep Rubio Palau

Dr Josep Rubio Palau

Prestigious specialist in Oral and Maxillofacial Surgery

Dra Marta Leiva Repiso

Dra Marta Leiva Repiso

Associate Professor Department of Animal Medicine and Surgery at the Autonomous University of Barcelona, Dipl ECVO, PhD, DVM

Txema Castelar Cifuentes

Txema Castelar Cifuentes

Clinical veterinarian (MD) Expert in echography

Dr García Linares

Dr García Linares

Renowned specialist in Oral and Maxillofacial Surgery

Dr Roland Glauser

Dr Roland Glauser

Expert dental surgeon, MD

Magnus Persson

Magnus Persson

Director Sales Europe Zircon Medical

Dr Lluís Peri

Dr Lluís Peri

Head of Functional and Reconstructive Urology Section at Hospital Clínic de Barcelona

Mª Teresa Peña Giménez

Mª Teresa Peña Giménez

Professor Department of Animal Medicine and Surgery at the Autonomous University of Barcelona, Dipl ECVO, PhD, DVM

Peter-Paul Fransen

Peter-Paul Fransen

Managing Director and Co-Founder of UPyTher

Geert van Almen

Geert van Almen

CEO and Co-Founder of UpyTher

Montse Jorro

Montse Jorro

Clinical veterinarian (MD) Expert in Cardiology

Teresa Gasull

Teresa Gasull

Senior Research Investigator & Team leader of the CMN group

Juan M Carretero Bellón

Juan M Carretero Bellón

Paediatric Cardiology at Hospital Sant Joan de Déu

Prof Jordi Monés

Prof Jordi Monés

Ophthalmologist specialized in diseases of the macula, retina and vitreous humour

02 / Partnerships

Pioneering companies in the field of health:

top_bars_icon

Related projects

Stay up to date with all Versa Biomedical news, events and achievements.

A swine model of selective geographic atrophy of outer retinal layers mimicking atrophic AMD: A phase I escalating dose of subretinal sodium iodate

Despite recent advances in treatment of the wet form of AMD,1–6 the clinical outcome of AMD often remains blindness. Nowadays, the great challenge to which the ophthalmologic community is committed lies in finding a treatment that may slow the relentless progression of the atrophic form of the disease, together with other approaches that restore or regenerate the involved part of the diseased retinal tissue. Nowadays, the advanced form of dry AMD with geographic atrophy (GA) may be the first cause of legal blindness among elderly patients in the industrialized world, and it represents up to a third of cases of late AMD.7,8 Besides the impact of the disease among individuals, the economic burden of atrophic AMD (drusen, RPE abnormalities, and/or GA) in the United States is enormous: $26,100 million annually in one study9 and approximately 0.22% of its gross domestic product in 2010 in terms of wage loss from untreated disease in another report.10 Download case

Abstract of the publication:

Purpose

To establish the dose of subretinal sodium iodate (NaIO3) in order to create a toxin-induced large animal model of selective circumscribed atrophy of outer retinal layers, the retinal pigment epithelium (RPE), and photoreceptors, by spectral-domain optical coherence tomography (SD-OCT) and immunocytochemistry.

Methods

Fifteen male and female healthy Yorkshire pigs received unilateral subretinal escalating doses of NaIO3 under general anesthesia. In all the animals, volumes of 0.1 to 0.2 mL NaIO3 were injected into the subretinal space of the area centralis through a 23/38-gauge subretinal cannula. Control SD-OCTs were performed 1 and 2 months after the surgery, at which time pigs were euthanized and eyes enucleated. Globes were routinely processed for histologic and immunohistochemical evaluation.

Results

Spectral-domain OCT and immunohistochemistry revealed circumscribed and well-demarcated funduscopic lesions, limited to the outer retinal layers in pigs treated with 0.01 mg/mL subretinal sodium iodate.

Conclusions

The swine model of a controlled area of circumscribed retinal damage, with well-delimited borders, and selectively of the outer layers of the retina presented herein shows several clinical and histologic features of geographic atrophy in AMD. Therefore, it may represent a valuable tool in the investigation of new emerging regenerative therapies that aim to restore visual function, such as stem cell transplantation or optogenetics.

Go to project

Dental implant research

Despite recent advances in treatment of the wet form of AMD,1–6 the clinical outcome of AMD often remains blindness. Nowadays, the great challenge to which the ophthalmologic community is committed lies in finding a treatment that may slow the relentless progression of the atrophic form of the disease, together with other approaches that restore or regenerate the involved part of the diseased retinal tissue. Nowadays, the advanced form of dry AMD with geographic atrophy (GA) may be the first cause of legal blindness among elderly patients in the industrialized world, and it represents up to a third of cases of late AMD.7,8 Besides the impact of the disease among individuals, the economic burden of atrophic AMD (drusen, RPE abnormalities, and/or GA) in the United States is enormous: $26,100 million annually in one study9 and approximately 0.22% of its gross domestic product in 2010 in terms of wage loss from untreated disease in another report.10

Download case

Abstract of the publication:

Purpose

To establish the dose of subretinal sodium iodate (NaIO3) in order to create a toxin-induced large animal model of selective circumscribed atrophy of outer retinal layers, the retinal pigment epithelium (RPE), and photoreceptors, by spectral-domain optical coherence tomography (SD-OCT) and immunocytochemistry.

Methods

Fifteen male and female healthy Yorkshire pigs received unilateral subretinal escalating doses of NaIO3 under general anesthesia. In all the animals, volumes of 0.1 to 0.2 mL NaIO3 were injected into the subretinal space of the area centralis through a 23/38-gauge subretinal cannula. Control SD-OCTs were performed 1 and 2 months after the surgery, at which time pigs were euthanized and eyes enucleated. Globes were routinely processed for histologic and immunohistochemical evaluation.

Results

Spectral-domain OCT and immunohistochemistry revealed circumscribed and well-demarcated funduscopic lesions, limited to the outer retinal layers in pigs treated with 0.01 mg/mL subretinal sodium iodate.

Conclusions

The swine model of a controlled area of circumscribed retinal damage, with well-delimited borders, and selectively of the outer layers of the retina presented herein shows several clinical and histologic features of geographic atrophy in AMD. Therefore, it may represent a valuable tool in the investigation of new emerging regenerative therapies that aim to restore visual function, such as stem cell transplantation or optogenetics.

Go to project

Establishment of a reproducible and minimally invasive ischemic stroke model in swine

Despite recent advances in treatment of the wet form of AMD,1–6 the clinical outcome of AMD often remains blindness. Nowadays, the great challenge to which the ophthalmologic community is committed lies in finding a treatment that may slow the relentless progression of the atrophic form of the disease, together with other approaches that restore or regenerate the involved part of the diseased retinal tissue. Nowadays, the advanced form of dry AMD with geographic atrophy (GA) may be the first cause of legal blindness among elderly patients in the industrialized world, and it represents up to a third of cases of late AMD.7,8 Besides the impact of the disease among individuals, the economic burden of atrophic AMD (drusen, RPE abnormalities, and/or GA) in the United States is enormous: $26,100 million annually in one study9 and approximately 0.22% of its gross domestic product in 2010 in terms of wage loss from untreated disease in another report.10 Download case

Abstract of the publication:

Purpose

To establish the dose of subretinal sodium iodate (NaIO3) in order to create a toxin-induced large animal model of selective circumscribed atrophy of outer retinal layers, the retinal pigment epithelium (RPE), and photoreceptors, by spectral-domain optical coherence tomography (SD-OCT) and immunocytochemistry.

Methods

Fifteen male and female healthy Yorkshire pigs received unilateral subretinal escalating doses of NaIO3 under general anesthesia. In all the animals, volumes of 0.1 to 0.2 mL NaIO3 were injected into the subretinal space of the area centralis through a 23/38-gauge subretinal cannula. Control SD-OCTs were performed 1 and 2 months after the surgery, at which time pigs were euthanized and eyes enucleated. Globes were routinely processed for histologic and immunohistochemical evaluation.

Results

Spectral-domain OCT and immunohistochemistry revealed circumscribed and well-demarcated funduscopic lesions, limited to the outer retinal layers in pigs treated with 0.01 mg/mL subretinal sodium iodate.

Conclusions

The swine model of a controlled area of circumscribed retinal damage, with well-delimited borders, and selectively of the outer layers of the retina presented herein shows several clinical and histologic features of geographic atrophy in AMD. Therefore, it may represent a valuable tool in the investigation of new emerging regenerative therapies that aim to restore visual function, such as stem cell transplantation or optogenetics.

Go to project

Specipig miniature pig in metabolic disease insulin independent SC administration PK study

Despite recent advances in treatment of the wet form of AMD,1–6 the clinical outcome of AMD often remains blindness. Nowadays, the great challenge to which the ophthalmologic community is committed lies in finding a treatment that may slow the relentless progression of the atrophic form of the disease, together with other approaches that restore or regenerate the involved part of the diseased retinal tissue. Nowadays, the advanced form of dry AMD with geographic atrophy (GA) may be the first cause of legal blindness among elderly patients in the industrialized world, and it represents up to a third of cases of late AMD.7,8 Besides the impact of the disease among individuals, the economic burden of atrophic AMD (drusen, RPE abnormalities, and/or GA) in the United States is enormous: $26,100 million annually in one study9 and approximately 0.22% of its gross domestic product in 2010 in terms of wage loss from untreated disease in another report.10 Download case

Abstract of the publication:

Purpose

To establish the dose of subretinal sodium iodate (NaIO3) in order to create a toxin-induced large animal model of selective circumscribed atrophy of outer retinal layers, the retinal pigment epithelium (RPE), and photoreceptors, by spectral-domain optical coherence tomography (SD-OCT) and immunocytochemistry.

Methods

Fifteen male and female healthy Yorkshire pigs received unilateral subretinal escalating doses of NaIO3 under general anesthesia. In all the animals, volumes of 0.1 to 0.2 mL NaIO3 were injected into the subretinal space of the area centralis through a 23/38-gauge subretinal cannula. Control SD-OCTs were performed 1 and 2 months after the surgery, at which time pigs were euthanized and eyes enucleated. Globes were routinely processed for histologic and immunohistochemical evaluation.

Results

Spectral-domain OCT and immunohistochemistry revealed circumscribed and well-demarcated funduscopic lesions, limited to the outer retinal layers in pigs treated with 0.01 mg/mL subretinal sodium iodate.

Conclusions

The swine model of a controlled area of circumscribed retinal damage, with well-delimited borders, and selectively of the outer layers of the retina presented herein shows several clinical and histologic features of geographic atrophy in AMD. Therefore, it may represent a valuable tool in the investigation of new emerging regenerative therapies that aim to restore visual function, such as stem cell transplantation or optogenetics.

Go to project